Topical tacrolimus suppresses the expression of vascular endothelial growth factor and insulin-like growth factor-1 in late anagen

Clinical and Experimental Dermatology

Volumn 34, Issue 8, 2009, Pages

  Wang, Y ^a   Yang, S ^a   Wu, L ^a   Tu, P ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; TACROLIMUS; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HAIR FOLLICLE; HAIR GROWTH; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN COLOR; SKINFOLD THICKNESS;

ADMINISTRATION, TOPICAL; ANIMALS; DERMATOLOGIC AGENTS; HAIR FOLLICLE; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; TACROLIMUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 72549109495     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03339.x     Document Type: Article

References (10)

1. Ward KM, Barnett C, Fox LP et al. Eyelash trichomegaly associated with systemic tacrolimus. Arch Dermatol 2006 142 : 248.
2. Yano K, Brown LF, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 2001 107 : 409 417.
3. Jamin C. Androgenetic alopecia. Ann Dermatol Venereol 2002 129 : 801 803.
4. Goldman CK, Tsai JC, Soroceanu L et al. Loss of vascular endothelial growth factor in human alopecia hair follicles. J Invest Dermatol 1995 104 : 18S 20S.
5. Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996 76 : 1005 1026.
6. Tang L, Bernardo O, Bolduc C et al. The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia. J Am Acad Dermatol 2003 49 : 229 233.
7. Slominski A, Paus R. Melanogenesis is coupled to murine anagen. toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol 1993 101 : 90S 7S.
8. Paus R, Handjiski B, Czarnetzki BM et al. A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J Invest Dermatol 1994 103 : 143 147.
9. Yamamoto S, Jiang H, Kato R. Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. J Invest Dermatol 1994 102 : 160 164.
10. Josko J, Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit 2004 10 : RA89 98.